THERAPEUTIC REGIME AND METHODS OF TREATING MULTIPLE SCLEROSIS USING OFATUMUMABA
CY1126291T1Undetermined Publication Date: 2026-07-31NOVARTIS AG
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- CY20231100421T
- Authority / Receiving Office
- CY · CY
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2016-08-15
- Filing Date
- 2023-08-23
- Publication Date
- 2026-07-31
- Estimated Expiration
- 2043-08-23
Abstract
The disclosure is directed to therapeutic regimens for the treatment of Multiple Sclerosis (MS). These methods utilize the administration to the patient of ofatumumab, an anti-CD20 monoclonal antibody, during a loading dosage regimen and a maintenance regimen.
Need to check novelty before this filing date? Find Prior Art